Rapid Evidence Reviews on COVID-19 Management


Rapid Evidence Reviews on COVID-19 Management

Through the volunteer work of more than 50 EBM practitioners, methodologists and students from the UP Institute of Clinical Epidemiology and Asia-Pacific Center for Evidence-Based HealthCare, PSMID had graciously agreed to host these rapid evidence reviews on COVID19. The aim is to retrieve, appraise, summarize and update the available evidence on COVID-related management, to assist the frontline health workers, local policymakers and government officials in their evidence-based critical decision-making.

The reviews should not replace individual clinical judgement and the sources cited should be checked. The views are not a substitute for professional medical advice. The views expressed represent the views of the authors and not necessarily those  of their host institutions. This may change as new evidences emerges.

A discussion of the general methods used can be found here: Rapid Evidence Review General Methods.

This initiative is coordinated Dr. Leonila F. Dans and Dr. Ian Cabaluna.

For any questions or information, please email covidrapidreviewteam@gmail.com.

1. Prophylaxis

2. Adjunct Therapy

3. Treatment

3.1. Antiviral

3.2. Immunomodulator

3.3. Combination

4. Conservation of PPE

5. Diagnostics

6. Prognosis

7. Harm

8. Pediatric Concerns

9. Others